These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13692657)

  • 1. Study on the red cells sediment after clotting of polycythaemic blood.
    CHAUDHURI S; SOULIER JP
    Thromb Diath Haemorrh; 1960 Dec; 5():304-13. PubMed ID: 13692657
    [No Abstract]   [Full Text] [Related]  

  • 2. Moving boundary electrophoresis and sialic acid content of normal and polycythaemic red blood cells.
    Streichman S; Segal E; Tatarsky I; Marmur A
    Br J Haematol; 1981 Jun; 48(2):273-9. PubMed ID: 7236526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood coagulation changes in polycythemia vera. I].
    BURGER T; NAGY I; KESZTHELYI B; PEER J
    Pathol Biol; 1962 Apr; 103():687-9. PubMed ID: 13874811
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the defects in the blood coagulation mechanisms in polycythemia vera.
    ABRAHAM JP; ULUTIN ON; JOHNSON SA; CALDWELL MJ
    Am J Clin Pathol; 1961 Jul; 36():7-15. PubMed ID: 13681082
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiology and morphology of blood coagulation in polycythemia vera.
    JAMES TN; JOHNSON SA; MONTO RW
    J Appl Physiol; 1960 Nov; 15():1049-52. PubMed ID: 13789322
    [No Abstract]   [Full Text] [Related]  

  • 6. The circulating red blood cell volume. I. Its relationship to the peripheral blood cell counts in normal subjects and persons with polycythemia.
    LICHTMAN HC; RABINER SF
    AMA Arch Intern Med; 1957 Jan; 99(1):8-13. PubMed ID: 13393828
    [No Abstract]   [Full Text] [Related]  

  • 7. The life span of the red blood cell in chronic leukemia and polycythemia.
    BERLIN NI; LAWRENCE JH; LEE HC
    Science; 1951 Oct; 114(2963):385-7. PubMed ID: 14883866
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxygen and the control of red cell production in primary and secondary polycythemia; effects on the iron turnover patterns with Fe59 as tracer.
    LAWRENCE JH; ELMLINGER PJ; FULTON G
    Cardiologia (Basel); 1952; 21(4):337-46. PubMed ID: 13019789
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factor V and factor VII content in polycythemia vera].
    THIES HA; SAUER H
    Klin Wochenschr; 1955 Jun; 33(23-24):591-2. PubMed ID: 14392899
    [No Abstract]   [Full Text] [Related]  

  • 10. [The chemical element content of the erythrocytes in polycythemia vera].
    Vydyborets SV; Tishchenko LM
    Vrach Delo; 1989 Oct; (10):80-1. PubMed ID: 2617995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma erythropoietic-stimulating factor in man; observations on patients with polycythemia vera and secondary polycythemia.
    BETHELL FH; LINMAN JW
    J Lab Clin Med; 1957 Jan; 49(1):113-27. PubMed ID: 13385582
    [No Abstract]   [Full Text] [Related]  

  • 12. The electrolytic resistance of the blood clot in polycythemia vera before and after radiation and its relationship to clot retraction.
    HENSTELL HH; HENSTELL IS; ORNITZ EM
    Am J Clin Pathol; 1951 Sep; 21(9):820-7. PubMed ID: 14877772
    [No Abstract]   [Full Text] [Related]  

  • 13. The "escape" phenomenon of polycythemia vera: its relation to hemorrhage and thrombosis in the disease.
    SHEEHY TW; MONTALVO G
    Am J Med Sci; 1962 Feb; 243():183-92. PubMed ID: 13911560
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving boundary electrophoresis of red cells on differently treated polycythaemic patients.
    Streichman S; Antebi D; Tatarsky I
    Scand J Haematol; 1983 Oct; 31(4):392-5. PubMed ID: 6622979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycythemia vera; study of coagulation abnormalities, both thrombotic and hemorrhagic.
    WILSON SJ; HEATH HE; LARSEN WE
    J Kans Med Soc; 1958 Mar; 59(3):90-2. PubMed ID: 13514189
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation.
    Tan X; Shi J; Fu Y; Gao C; Yang X; Li J; Wang W; Hou J; Li H; Zhou J
    Thromb Haemost; 2013 Jun; 109(6):1025-32. PubMed ID: 23571603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between clotting activity and phosphatidylserine expression on erythrocyte membranes in polycythemia vera patients with the JAK2 V617F mutation.
    Fujita H; Sakuma R; Tomiyama J; Hamaki T; Ohwada A; Nishimura S
    Arch Physiol Biochem; 2011 Oct; 117(4):231-5. PubMed ID: 21539404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemoglobin content of the blood in anemia, polycythemia vera & polyglobulisms].
    RICHTER K
    Klin Wochenschr; 1958 Oct; 36(19):911-4. PubMed ID: 13599441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulation disorders in erythremia, a consideration of the significance of the third phase of coagulation in the organism].
    REIMANN F
    Tip Fak Mecm; 1955; 18(1):418-37. PubMed ID: 13256519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of the hyperglobulia factor in the hemostasis in patients with erythremia].
    Promakhina EK; Titugin IuM; Kopteva IA
    Gematol Transfuziol; 1983 Aug; 28(8):16-9. PubMed ID: 6628940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.